1. Cancer Biology
  2. Medicine
Download icon

Cancer Immunotherapy: A promising platform for predicting toxicity

  1. Maria Ochoa de Olza  Is a corresponding author
  1. Lausanne University Hospital, Switzerland
Insight
Cite this article as: eLife 2021;10:e73191 doi: 10.7554/eLife.73191
1 figure

Figures

Testing drug toxicity using an organ-on-chip platform.

Administering TCBs to an organ-on-chip platform (such as a model of the lung or intestine) allows the antibodies (Y-shaped structures) to recognize antigens (shown in yellow and blue) present in both healthy epithelial and cancerous cells. This brings T cells close to their targets and also activates them, which can lead to healthy cells being damaged (as assessed by measuring cell death and inflammation levels). This model is able to partially reproduce toxicity observed in animals and humans.

Image credit: Image was prepared with Servier Medical Art (CC BY 3.0).

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Download citations (links to download the citations from this article in formats compatible with various reference manager tools)

Open citations (links to open the citations from this article in various online reference manager services)